Lis Technologies, a developer owner of advanced laser technology and the only US and patented laser uranium enrichment company, announced that it had closed its third consecutive overwhelming financing stay of $ 11.93 million, which has allowed a total of more than $ 47 million to date. The financing tour has seen the continuous support of repeated investors, including innovative capital, as well as other leading, experienced and industry in advanced nuclear technology.
With high demand in the United States for an interior nuclear fuel supply chain, as well as the solid support of return investors, the company’s recent financing tower was overwritten. This funding highlights the position of the list as a leading leader in the American enriched fuel market and validates the success of the company to attract and retain the best researchers, scientists, regulatory experts and former American national leaders to help stimulate the rebirth of the only patented laser-enrichment technology in the country.
At the end of 2024, Lis Technologies was chosen as one of the six national companies to participate in the enrichment acquisition program with low enrichment of uranium (LEU). And this initiative allocates up to $ 3.4 billion overall, with contracts of a duration up to 10 years. Each scholarship holder should receive a minimum contract of $ 2 million.
The repression ownership of the company’s condensation is the selective laser activation technology (Crisla) is the only advanced laser -advanced enrichment solution. Optimized for low-enrichment uranium (LEU), which is essential for the continuous functioning of the current current fleet of the United States of 94 nuclear reactors, and of low-investigation uranium (half-line), which is necessary to fuel the next generation of advanced nuclear reactors, crisla outdates many complexes and lasers to lasers to traditional 16um Its complexity and lower and low lasers lower wavelength at 5.3 µm. And the technology of separation of the isotopes of the laser Crisla-3g was recently evaluated and determined to respond to all the elements required for TRL-4, in accordance with the guide to the Ministry of Energy Doe G 413.3-4A and is protected by a certificate from the American Patent and the brand (USPTO).
The funding obtained in this Tour will allow the company to advance in its next growth phase. And this includes systems engineering, integration and tests of our testing testing installation in our newly improved laboratories at Oak Ridge TN, while developing the own owners of the list in the United States. The objective over the next two years is not only to repeat the previous reference results, but to optimize it, then demonstrate that technology can produce Leu in a single step, and bears in two stages, with fully on -scale and industrialized equipment.
For which funding will be used: Funding also allows the company to diversify Crisla technology in stable isotopes and medical isotopes.
Key quotes:
“Despite the Volatile Market Conditions of this Year, we continue to deliver on objective, and investors clearly recognize the value of our progress. This marks Our Third Consecuative Oversubecubed Financing Round, Highlighting Investor’s Confidence in List’s Seasoned Management Team and Our Mission to Revive The Only US-Origin, Patented Laser Enrichment Technology, Which was independently Evaluled and Determined to Meet All Elements Required for TRL-4, conforming to the Department of Energy Guide Doe G 413.3-4A.
Jay Yu, Executive President and President of Lis Technologies
“The success of this increase and our previous increases highlights the confidence that investors have in our mission, our team and our technology. This increase will allow us to continue increasing operations, to add more technical engineers, regulatory managers and to quickly advance our projects, which would be closer to crucial demonstration activities to achieve business growth objectives. ”
Christo Liebenberg, co-founder and CEO of Lis Technologies